CIK 0001133869 · Non-accelerated filer<br>Smaller reporting company
CAPRICOR THERAPEUTICS, INC.
Sign in to watch- Ticker
- CAPR
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- (310) 358-3200
- Business address
- 10865 ROAD TO THE CURE, SUITE 150, SAN DIEGO, CA, 92121
- Former names
- Nile Therapeutics, Inc., SMI PRODUCTS INC
- SC 13D/A Stake Beneficial Ownership Report
- SC 13D/A Stake Beneficial Ownership Report
- 4 Open-market buy 10% owner bought 416,666 shares at $2.40 ($999,998)
- 4 Open-market buy CHIEF FINANCIAL OFFICER bought 2,100 shares at $2.40 ($5,040)
- 4 Open-market buy EVP, General Counsel bought 4,060 shares at $2.40 ($9,744)
- 4 Open-market buy Chief Executive Officer bought 10,152 shares at $2.40 ($24,365)
- 4 Open-market buy Vice President of Finance bought 2,030 shares at $2.40 ($4,872)
- 4 Open-market buy Director bought 100,000 shares at $2.40 ($240,000)
- 4 Open-market buy Director bought 91,369 shares at $2.40 ($219,286)
- 4 Open-market buy 10% owner bought 833,332 shares at $2.40 ($1,999,997)
- 8-K Event Results of operations · Regulation FD disclosure
- 8-K/A Event Material agreement · Unregistered share sale
- 424B5 Offering Prospectus
- 8-K Event Material agreement · Unregistered share sale · Other events
- 4 Derivatives Options or other derivatives
- 8-K Event Regulation FD disclosure
- 3 Insider Initial Statement of Ownership
- 8-K Event Executive or director change
- 8-K Event Other events
- 5 Insider Annual Insider Trading Report
Page 27 of 49 · 965 filings